Go to deals
Private Equity | Healthcare

Natus welcomes Optima Medical to the Natus family of solutions

The shareholders of Optima Medical Limited have sold the company to Natus Medical Incorporated.

Optima Medical is one of the UK and Ireland’s leading supplier of neurodiagnostic equipment and accessories (EEG, Sleep, EMG, IOM). Since it was founded in 1999, Optima has installed thousands of systems in hospitals throughout the UK and Ireland. The company has built its reputation through supplying high-performance equipment combined with technical and clinical expertise. Its team consists of highly experienced engineers, product experts and clinical specialists trained and qualified to support customers throughout the life of their equipment.

Natus delivers solutions to screen, diagnose and treat disorders affecting the brain, neural pathways and eight sensory nervous systems, its aim being to advance the standard of care and improve patient outcomes and quality of life. Natus offers hardware, advanced software and algorithms, and consumables that provide stimulus, acquire and monitor physiological signals, and capture the body’s response. With sales in over 100 countries, Natus is a global leader in neurodiagnostics.

With a long-standing history as a trusted distribution partner of Natus Medical, the acquisition of Optima signifies a significant step forward, elevating their already successful partnership to a new phase. Together, they are able to enhance their shared goal of providing industry leading products and exceptional customer support, bringing it closer to their customers within the British Isles.

Oaklins S&W, based in the UK, acted as lead advisor to the shareholders of Optima.

Parties

Talk to the deal team

Stuart Goodman

Partner
London, United Kingdom
Oaklins S&W

Ben Laing

Partner
London, United Kingdom
Oaklins S&W

Related deals

Valmiermuižas Alus has been acquired by Cēsu Alus
Private Equity | Food & Beverage

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more
Capsol has been acquired by Angus Capital
Private Equity | Construction & Engineering Services

Capsol has been acquired by Angus Capital

Capsol has been acquired by Angus Capital as part of its strategy to build a leading construction services group alongside other portfolio companies. This partnership marks a new phase of growth for Capsol, providing the platform, resources and strategic support needed to accelerate its development and expand its market presence.

Learn more